Xpert Xpress Strep A, XPRSTREPA-10, P/N: 302-2294 IVD, Rx Only

FDA Device Recall #Z-0215-2024 — Class II — April 24, 2023

Recall Summary

Recall Number Z-0215-2024
Classification Class II — Moderate risk
Date Initiated April 24, 2023
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Cepheid
Location Sunnyvale, CA
Product Type Devices
Quantity 89,958 kits ( 10 test per kit)

Product Description

Xpert Xpress Strep A, XPRSTREPA-10, P/N: 302-2294 IVD, Rx Only

Reason for Recall

pipettes packaged in Strep A test may fail to dispense an adequate sample volume which could result in "invalid" results or no result test results.

Distribution Pattern

Worldwide distribution - US Nationwide and the countries of Costa Rica, Ireland, Estonia, United Kingdom, Germany, Italy, Greece, Poland, Switzerland, Hong Kong, United Arab Emirates.

Lot / Code Information

UDI: (01)07332940006372/ Lots: 23718 23719 23720 10309 23201 23305 23308 23312 23314 23315 23401 23402 23403 23404 23405 23406 23407 23501 23504 23505 23506 23408 23410 23510 23411 23604 23605 23607 23608 23609 23610 23611 23612 23701 23702 23703 23705 23706 23707 23708 23709 23710 23711 23712 23714 23716 23717 23113 23316 23912 24112 23820 24704 24302 24307 24507 24508 24511 23822 23823 23824 24512 24513 24514 23825 24313 24515 24516 24517 24805

Other Recalls from Cepheid

Recall # Classification Product Date
Z-0724-2026 Class II Xpert MTB/RIF. Model Number: GXMTB/RIF-US-10. Nov 5, 2025
Z-0960-2026 Class II Brand Name: Xpert¿ BCR-ABL Ultra Model/Catalog... Oct 30, 2025
Z-0959-2026 Class II Brand Name: Xpert¿ BCR-ABL Ultra Model/Catalog... Oct 30, 2025
Z-0414-2026 Class II Xpert SA Nasal Complete Catalog Number: GXSACO... Aug 6, 2025
Z-2584-2024 Class II Cepheid, Sample Collection Device, Part: 900-0370 Jun 20, 2024

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.